| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/19/2009 | CA2698754A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698748A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698745A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698693A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698691A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698682A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698666A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2697756A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
| 03/19/2009 | CA2686439A1 Compound and device for treating bone and/or cartilage defects |
| 03/18/2009 | EP2036978A1 Recombinant preparation of selected bromelain fractions |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2036925A1 Novel steroid-activated nuclear receptors and uses therefor |
| 03/18/2009 | EP2036924A2 Gene regulatory peptides |
| 03/18/2009 | EP2036923A1 Improved derivates of amylin |
| 03/18/2009 | EP2036922A1 Novel antihypertensive peptide and use thereof |
| 03/18/2009 | EP2036918A1 Peptide derivative |
| 03/18/2009 | EP2036573A1 HLA binding peptides and their uses |
| 03/18/2009 | EP2036572A1 Process for drying a protein, a protein particle and a pharmaceutical composition comprising the protein particle |
| 03/18/2009 | EP2036571A1 Use of G-CSF for treating strokes |
| 03/18/2009 | EP2036570A1 Means and methods for influencing platelet-collagen interaction |
| 03/18/2009 | EP2036569A2 Method for Treating Secondary Immunodeficiency |
| 03/18/2009 | EP2036567A2 Modulation of the P2Y2 receptor pathway |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036544A1 Dosage form of powder agglomerates |
| 03/18/2009 | EP2036541A1 Methods and compositions for pulmonary delivery of insulin |
| 03/18/2009 | EP2036539A1 Stable formulations of amylin and its analogues |
| 03/18/2009 | EP2035556A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
| 03/18/2009 | EP2035453A2 Cd4 mimic peptides and their uses |
| 03/18/2009 | EP2035451A1 Insulinotropic peptide synthesis |
| 03/18/2009 | EP2035448A2 Neuroactive fragments of app |
| 03/18/2009 | EP2035445A2 Polynucleotides encoding novel pcsk9 variants |
| 03/18/2009 | EP2035444A2 Dipeptide compounds containing d-histidine |
| 03/18/2009 | EP2035051A1 Composite preparation process on a basis of bioceramics and biodegradable or non biodegradable polymers, cementing and/or carrier substances containing encapsulated or non-encapsulated micro or nanoparticulated antibiotics and angiostensin (1-7) for tissue restitution and products therefrom |
| 03/18/2009 | EP2035032A2 Methods for ester detoxication |
| 03/18/2009 | EP2035031A2 Insulin composition |
| 03/18/2009 | EP2035030A2 Use of a soluble morphogenic protein complex for treating cartilage defects |
| 03/18/2009 | EP2035029A2 Peptide compounds for treating refractory status epilepticus |
| 03/18/2009 | EP2035028A2 Methods for treating autoimmune diseases using a taci-ig fusion molecule |
| 03/18/2009 | EP2034955A2 Collagen scaffolds, medical implants with same and methods of use |
| 03/18/2009 | EP2034816A1 O-glycans in the treatment of inflammatory bowel disease and cancers |
| 03/18/2009 | EP2000483A9 Vegf receptor fusion protein and use thereof |
| 03/18/2009 | EP1987144A4 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh |
| 03/18/2009 | EP1978989A4 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 03/18/2009 | EP1869081A4 POP2 NFkB-INHIBITING POLYPEPTIDES, NUCLEIC ACIDS AND METHODS OF USE |
| 03/18/2009 | EP1845797B1 Food products comprising hydrolysed milk solids with improved taste |
| 03/18/2009 | EP1517918B1 Peptides having affinity for a phospholipid and uses |
| 03/18/2009 | EP1515745B1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/18/2009 | EP1462112B1 Remedies for dry eye and diseases associated with dry eye |
| 03/18/2009 | EP1399499B1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 03/18/2009 | EP1343815B1 Antibacterial treatments |
| 03/18/2009 | EP1292316B1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 03/18/2009 | EP1218498B1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 03/18/2009 | EP1185288A4 Hemoactive compositions and methods for their manufacture and use |
| 03/18/2009 | EP1140139B2 Use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
| 03/18/2009 | EP1095136B1 Cells and animals deficient in protein kinase c epsilon |
| 03/18/2009 | EP1077678A4 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 03/18/2009 | EP0865499B1 Production of lysosomal enzymes in plant-based expression systems |
| 03/18/2009 | EP0814834B2 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 03/18/2009 | EP0741783B1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 03/18/2009 | CN101389963A Vascular tumor markers |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101389759A De-differentiation of astrocytes into neural stem cell using shh |
| 03/18/2009 | CN101389653A Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| 03/18/2009 | CN101389652A T cell receptors which specifically bind to VYGFVRACL-HLA-A24 |
| 03/18/2009 | CN101389650A Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| 03/18/2009 | CN101389648A Oxyntomodulin derivatives |
| 03/18/2009 | CN101389647A Selective vpac2 receptor peptide agonists |
| 03/18/2009 | CN101389643A Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 03/18/2009 | CN101389642A Cyclic antimicrobial peptides |
| 03/18/2009 | CN101389353A Enteric gelatinous nutrient and method of preparing the same |
| 03/18/2009 | CN101389348A A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 03/18/2009 | CN101389347A Improved antitumoral treatments |
| 03/18/2009 | CN101389346A Human glp-1 mimetibodies, compositions, methods and uses |
| 03/18/2009 | CN101389345A Combinatorial methods and compositions for treatment of melanoma. |
| 03/18/2009 | CN101389273A 基因或药物递送系统 Gene or drug delivery systems |
| 03/18/2009 | CN101386677A Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101386644A Pumpkin protein 2 and preparation method and application thereof |
| 03/18/2009 | CN101386640A Variant cathelicidin-BF15 of cathelicidin-BF and use thereof |
| 03/18/2009 | CN101385859A Glutathione based delivery system |
| 03/18/2009 | CN101385858A Purified PEG human growth hormone conjugates and preparation thereof |
| 03/18/2009 | CN101385856A Controllable slow-releasing nano hydroxyapatite with efficient absorption for antalzyme and preparation method thereof |
| 03/18/2009 | CN101385852A Preparation method of bone collagen tablet |
| 03/18/2009 | CN101385851A Methods and compositions for healing and repair of articular cartilage |
| 03/18/2009 | CN101385850A Treatment of cellular proliferative disorders |
| 03/18/2009 | CN101385849A Use of human source nitrosylation thioredoxin in preparing medicine for treating ischemic heart disease |
| 03/18/2009 | CN101385778A Ganjiaxin tablet |
| 03/18/2009 | CN101385762A Composition of starwort total glycosidoprotein, preparation method and uses thereof |
| 03/18/2009 | CN100469894C Method for preparing laver blood pressure-reducing peptide by using enzyme-membrane coupling technique and application thereof |
| 03/18/2009 | CN100469887C Carotene synthase gene and uses therefor |
| 03/18/2009 | CN100469871C Low pyrogen staphylokinase and its preparation method |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/18/2009 | CN100469791C Glucagon-like peptide-1 analogs |
| 03/18/2009 | CN100469790C Production of recombinant BMP-2 |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469788C 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives |
| 03/18/2009 | CN100469787C Method for the synthesis of derivatives of (2S,3AS,7AS)-1-[(S)-1-alanyl]-octahydro-1H-indole-2-carboxylic acid and use thereof for the synthesis of perindopril |
| 03/18/2009 | CN100469779C Inhibitors of interleukin-1beta converting enzyme |
| 03/18/2009 | CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases |
| 03/18/2009 | CN100469392C Antifungal medicine composition |